Company intelligence / Profile preview

Hong Kong Dailygreen Trade

Hong Kong, Hong Kong

Ownership: Private
Development stage: Other

Overview

Hong Kong Dailygreen Trade is a commercial-stage trading company specializing in the distribution of pharmaceutical intermediates, active pharmaceutical ingredients (APIs), and fine chemicals. The company serves as a bridge between manufacturers and global markets, providing a wide range of chemical compounds used in research and pharmaceutical manufacturing. Their product portfolio often includes steroids, selective androgen receptor modulators (SARMs), and various organic synthesis intermediates. They primarily operate as a supplier and exporter rather than a drug discovery or clinical development firm.

Modalities: Small molecule
Industry: Chemicals & Materials

Beyond the preview

Go deeper on Hong Kong Dailygreen Trade.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hong Kong Dailygreen Trade.

Explore the full profile